Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

C4 Therapeutics (CCCC) Shares Repurchased (2019 - 2025)

C4 Therapeutics (CCCC) has 5 years of Shares Repurchased data on record, last reported at $14000.0 in Q4 2025.

  • For Q4 2025, Shares Repurchased changed N/A year-over-year to $14000.0; the TTM value through Dec 2025 reached $193000.0, down 0.52%, while the annual FY2025 figure was $193000.0, 0.52% down from the prior year.
  • Shares Repurchased reached $14000.0 in Q4 2025 per CCCC's latest filing, down from $24000.0 in the prior quarter.
  • Across five years, Shares Repurchased topped out at $155000.0 in Q1 2025 and bottomed at $14000.0 in Q4 2025.
  • Average Shares Repurchased over 3 years is $71000.0, with a median of $85000.0 recorded in 2024.
  • Peak YoY movement for Shares Repurchased: soared 431.25% in 2024, then tumbled 71.76% in 2025.
  • A 3-year view of Shares Repurchased shows it stood at $16000.0 in 2023, then skyrocketed by 431.25% to $85000.0 in 2024, then plummeted by 83.53% to $14000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Repurchased were $14000.0 in Q4 2025, $24000.0 in Q3 2025, and $155000.0 in Q1 2025.